Navigation Links
Genetic Discovery May Improve Hepatitis C Treatment
Date:8/17/2009

Finding will help predict patient response to therapy, researchers say

MONDAY, Aug. 17 (HealthDay News) -- The first biomarker that predicts a patient's response to hepatitis C treatments has been identified by U.S. researchers.

The new marker is a single letter change -- a C instead of a T -- in a segment of DNA near the IL28B gene, according to the Duke University Medical Center team. They found it by studying the DNA of 1,671 people taking part in a study of hepatitis C treatments.

Not only does this biomarker predict who is most likely to respond to treatment and who isn't, it may solve the long-standing question of why responses to hepatitis C treatments vary so widely among racial and ethnic groups.

"For geneticists, understanding response to treatment for hepatitis C infection has been almost like a Holy Grail," study senior author David Goldstein, director of the Center for Human Genome Variation at Duke's Institute for Genome Sciences & Policy, said in a university news release.

"The side effects of hepatitis treatment can be brutal, and about half the time, the treatment fails to eradicate the virus. This discovery enables us to give patients valuable information that will help them and their doctors decide what is best for them. This is what personalized medicine is all about," Goldstein said.

The study appeared online Aug. 16 in the journal Nature.

Hepatitis C, one of the most common infections in the world, affects about 170 million people. Treatment typically involves 48 weeks of interferon plus the antiviral drug ribavirin. Black patients are less likely to respond to treatment than white patients, while East Asian patients seem to have the best response.

More information

The U.S. Centers for Disease Control and Prevention has more about hepatitis C.



-- Robert Preidt



SOURCE: Duke University Medical Center, news release, Aug. 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Genetic Link Suspected for Muscular Dystrophy
2. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
3. Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc.
4. March of Dimes Celebrates 50th Anniversary of Genetics Short Course
5. Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease
6. Genetic testing may be valuable in treating colorectal cancer
7. NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism: Fragile X
8. Studies Show Genetic Activity of Antioxidants
9. Genetic Variation Associated With Survival Advantage in African Americans With HIV
10. Study Shows a Link Between Schizophrenia & Genetic Mutations
11. Teen Behaviors Stem From Genetics, Environment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Discovery May Improve Hepatitis C Treatment
(Date:2/24/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... Yisrayl makes an astounding statement when he says that the entire Bible was written ... the current times so plainly that anyone should be able to see the time ...
(Date:2/24/2017)... ... 2017 , ... Congratulations to Head Over Heels’ elite gymnast ... Ms. Esparza qualified into this prestigious status after winning the Vault, Floor, ... Nevada. Frida is one of approximately 25 gymnasts in the nation who earns ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in Miami Beach to host its Swirl: Miami Wine Tasting Event on March ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, ... clients already in the state and in nearby New Hampshire, Massachusetts and Canada, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a ... today announced that Premier Research, a leading clinical development service provider, has selected ... becoming increasingly complex, due in part to an array of circumstances including the ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... and Strategies - 2016" report to their offering. ... The latest research Autism ... pricing data and benchmarks in the global Autism Spectrum Disorder market. ... What are the key drugs marketed for Autism Spectrum Disorder ...
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs Price ... in the global Oesophageal Cancer market. The research answers ... key drugs marketed for Oesophageal Cancer and their clinical attributes? How ...
Breaking Medicine Technology: